Breaking News

Trials & Filings in Brief: Nov. 11, 2013

By Gil Roth | November 11, 2013

Acasti, Alnylam, Galena, GW, Portola, Revalasio, Zalicus

Phase I
Galena tests ovarian cancer vaccine . . . read more

GW begins GBM trial . . . read more

Phase II
Portola compound reverses Xarelto . . . read more

Revalasio begins MS trial . . . read more

Zalicus’ Z160 fails in LSR, PHN studies . . . read more

Filings
Acasti files IND for CaPre . . . read more

Alnylam gets fast track for patisiran . . . read more

blog comments powered by Disqus